Imunon Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With Imnn-001
Imunon宣布,使用Imnn-001治疗新诊断的爱文思控股晚期卵巢癌患者,综合生存期增长了11.1个月。
Imunon Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With Imnn-001
Imunon宣布,使用Imnn-001治疗新诊断的爱文思控股晚期卵巢癌患者,综合生存期增长了11.1个月。
使用浏览器的分享功能,分享给你的好友吧